Upstream and Downstream Ways to Stop Airway Disease
Dec 1, 2020 10:00am ‐ Dec 1, 2020 1:00pm
Co-Chair(s):
- Michael Holtzman, MD, Washington University School of Medicine
- Philippa C. Marrack, PhD, HHMI/National Jewish Health
System‑Based Approaches to Learn from Asthma Remissions
Dec 1, 2020 10:05am ‐ Dec 1, 2020 10:30am
Speaker(s):
- Karen Affleck, PhD, GlaxoSmithKline
Correcting Post‑Viral Disease (including COVID and Its Cousins)
Dec 1, 2020 10:30am ‐ Dec 1, 2020 10:55am
Speaker(s):
- Michael J. Holtzman, MD, Washington University in St. Louis
Progress with TSLP Therapeutics in Lung Disease
Dec 1, 2020 10:55am ‐ Dec 1, 2020 11:20am
Speaker(s):
- Jonathan Corren, MD, University of California, Los Angeles
Silencing Transcription Factors and Pathogens in Asthma and COVID‑19: Two Biotechnology Vignettes
Dec 1, 2020 11:40am ‐ Dec 1, 2020 12:05pm
Speaker(s):
- David B. Corry, MD, Baylor College of Medicine
Navigating New Therapeutics for Asthma and COVID
Dec 1, 2020 12:05pm ‐ Dec 1, 2020 12:30pm
Speaker(s):
- Joseph R. Arron, MD, PhD, Genentech, Inc.
Short Talk: Asthma‑Associated Variants Induce IL33 Differential Expression through a Novel Regulatory Region
Dec 1, 2020 12:30pm ‐ Dec 1, 2020 12:45pm
Speaker(s):
- Ivy Aneas‑Swanson, PhD, University of Chicago
Short Talk: Modeling Airway Dysfunction in Asthma Using Synthetic Mucus Biomaterials
Dec 1, 2020 12:45pm ‐ Dec 1, 2020 1:00pm
Speaker(s):
- Gregg A. Duncan, PhD, University of Maryland